Eight Startup Semifinalists Selected for the Accenture HealthTech Innovation Challenge
December 08 2016 - 9:57AM
Business Wire
Companies chosen for ability to identify
innovative technology and creative solutions to improve the way
people access and manage healthcare
Giving people with disabilities the power to control objects
with their minds, automating breast health monitoring and a
wireless injectable device for connected drug delivery services are
among the innovative technologies being developed by the eight
semifinalists selected for the Accenture HealthTech Innovation
Challenge.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20161208005673/en/
The Accenture HealthTech Innovation Challenge brings together
leading-edge startups with prominent health and life sciences
organizations to tackle some of the world’s greatest health
challenges including access, affordability and transparency. The
eight semifinalists were chosen from more than 500 applicants by
leading industry executives from many of the largest health and
life sciences companies in the world.
“We’re extremely impressed with the energy and enthusiasm the
startups have demonstrated when creating solutions that could
disrupt the way traditional care is provided,” said Anne O’Riordan,
senior managing director of Accenture Life Sciences and co-author
of Healthcare Disrupted. “It’s exciting to work with the
entrepreneurs because, like Accenture, they picture a future where
technology solutions not only arm the health industry with
far-more-sophisticated, fine-tuned data but also improve the lives
of patients and provide better outcomes for healthcare
providers.”
The Accenture HealthTech Innovation Challenge semi-finalists
are:
- BrainControl, which fills a
technological void for patients that are cognitively aware, but
unable to move or communicate. Based on the proprietary
Brain-Computer Interface technology, it aims to give people with
certain disabilities the power to control objects with their minds,
allowing them to control a communicator, domestic devices (lights,
doors, windows, alarms, temperature, bed positions, etc.),
wheelchairs, and other assistive technology.
- CaptureProof, a medical
camera that aims to mitigate Health Insurance Portability and
Accountability Act (HIPAA) privacy risk by providing a visual
narrative by putting photos, videos, chat and sensor data directly
in the hands of patients and their doctors to better enable more
efficient care, communications and collaboration to monitor
progress, assess in historical health context and decide on optimal
healthcare approach.
- Cupris Health, which has
developed smartphone technologies connected to medical devices and
a secure software platform to better enable doctors to discuss
patient cases remotely and patients to receive diagnoses and advice
from doctors without having to see the doctor in person. This can
reduce unnecessary and expensive face-to-face consultations in
developed countries and extends medical expertise to those living
in remote areas in developing countries who might have limited
access to care.
- InnaMed, which helps
patients get their blood tests carried out in the waiting room at
the doctor’s office and even in the emergency room before they see
a doctor, enabling their caregiver to receive instant
analysis.
- MedxNote, which aims to provide
a secure and HIPPA-compliant communication platform for doctors and
healthcare providers to use features and tools that help maximize
productivity and workflow. The platform employs Mexbot, a chat bot
that connects doctors and nurses to hospital data from labs,
radiology, and electronic medical records to improve patient
care.
- Noona, a mobile service
supporting the remote monitoring of cancer patients and real-world
data collection to track symptoms and well-being between hospital
visits. It provides pharmaceutical companies with patient reported
outcomes data during clinical trials that can help with assessing
the value of new treatments.
- QuiO, which has developed a
real-time, wireless injection device and cloud platform for
connected drug delivery devices, providing connected software for
monitoring, engaging and supporting patients taking injectable
therapies.
- UE LifeSciences, Inc., a company
that designs and develops point-of-care, easy-to-use and affordable
cancer detection tools for use in the developing world, It has
created the iBreastExam, an FDA-approved, hand-held, battery
powered, wireless mHealth solution for early detection of breast
lesions for use by public and private health agencies.
“We will continue to connect startups from the Accenture
HealthTech Innovation Challenge with our clients to help foster new
ideas and drive rapid, low-cost solutions to the industry’s
toughest challenges as part of our Health Open Innovation
Ecosystem,” said Brian Kalis, managing director of digital health
at Accenture.
Selected finalists will deliver live presentations during the
Accenture HealthTech Innovation Challenge final round and awards
ceremony to an exclusive panel of judges, including representatives
from Aetna, AmerisourceBergen, Anthem, Bupa, Cardinal Health,
Merck, Mercy, Kaiser Permanente, Novartis, Shire, and UCB. The top
entrants will gain exposure and access to leading companies in
their target market or therapeutic area. They will also be
offered the opportunity to participate in StartUp Health’s
Launchpad program.
The final judging round will take place at the StartUp
Health Festival in San Francisco on January 9, 2017, during
the JP Morgan Healthcare Conference and will be livestreamed online
at Facebook.com/StartUpHealth. Accenture is the lead Innovation
Partner of the festival, which brings together more than 2,000 of
the world’s leading healthcare innovators and investors.
This program from Accenture Health and Life
Sciences is tied to Accenture Ventures, which identifies the
most promising sources of innovation in the market, using an open
innovation approach that involves working with start-ups,
entrepreneurs, investors, academic R&D, and corporate R&D
groups around the world. Accenture Ventures is a key element
of the Accenture Innovation Architecture which brings together the
company’s capabilities – from research, ventures and labs to
studios, innovation centers and delivery centers – to develop and
deliver disruptive innovations for clients, and to scale them
faster.
About Accenture
Accenture (NYSE:ACN) is a leading global professional services
company, providing a broad range of services and solutions in
strategy, consulting, digital, technology and operations. Combining
unmatched experience and specialized skills across more than 40
industries and all business functions – underpinned by the world’s
largest delivery network – Accenture works at the intersection of
business and technology to help clients improve their performance
and create sustainable value for their stakeholders. With
approximately 384,000 people serving clients in more than 120
countries, Accenture drives innovation to improve the way the world
works and lives. Visit us at www.accenture.com.
Accenture Disclaimer
Accenture’s support of the selected companies will help them as
they further develop their solutions and products. In
supporting such initiatives, however, Accenture is in no way
promoting or intending to market any one particular solution or
product or otherwise offer or market a medical device or clinical
solution. Each company uses its own operations to ensure compliance
with applicable laws and regulations.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161208005673/en/
AccentureJenn Francis, + 1 630 338
6426jennifer.francis@accenture.comorCam Granstra, + 1 312 693
5992cameria.l.granstra@accenture.com
Accenture (NYSE:ACN)
Historical Stock Chart
From Apr 2024 to May 2024
Accenture (NYSE:ACN)
Historical Stock Chart
From May 2023 to May 2024